30 studies found for:    " April 06, 2011":" May 06, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Treatment Advocacy Intervention for HIV-Positive African Americans
Condition: HIV
Intervention: Behavioral: Treatment Advocacy
2 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
3 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
4 Terminated
Has Results
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
5 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
6 Completed Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
7 Completed
Has Results
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
8 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
9 Completed Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Condition: Human Immunodeficiency Virus
Interventions: Drug: KM-023;   Drug: Placebo for KM-023
10 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
11 Unknown  Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
12 Active, not recruiting
Has Results
Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
13 Completed
Has Results
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C, Chronic;   HCV Coinfection
Intervention:
14 Completed Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
15 Completed Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
16 Completed
Has Results
Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
17 Recruiting Collection of Blood for Multiple Collaborative Studies
Condition: HIV
Intervention:
18 Completed TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.
Conditions: Hepatitis C;   HIV
Interventions: Drug: ETR/telaprevir;   Drug: TMC278/telaprevir;   Drug: telaprevir/ETR;   Drug: telaprevir/TMC278
19 Completed Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men
Conditions: Bisexually-active Men;   at Risk for HIV
Interventions: Behavioral: RISE life coaching intervention;   Behavioral: HIV Counseling
20 Terminated
Has Results
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Condition: HIV-1
Interventions: Drug: Maraviroc;   Drug: Emtricitabine/tenofovir;   Drug: darunavir/ritonavir 800/100 mg;   Drug: placebo for emtricitabine/tenofovir;   Drug: placebo for maraviroc

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years